-
Dalbavancin, sold
under the
brand names Dalvance in the US and
Xydalba in the EU
among others, is a second-generation
lipoglycopeptide antibiotic medication...
-
Ceftobiprole (5th generation)
Ceftaroline (5th generation)
Clindamycin Dalbavancin Delafloxacin Fusidic acid
Mupirocin (topical)
Omadacycline Oritavancin...
- the
company acquired Vicuron Pharmaceuticals and its drug candidate,
dalbavancin, a long-acting
semisynthetic lipoglycopeptide antibiotic, from Pfizer...
-
generation includes lipoglycopeptides like telavancin,
oritavancin and
dalbavancin. The
extra lipophilicity not only
enhances Lipid II binding, but also...
-
linked to glycopeptides. The
class includes oritavancin,
telavancin and
dalbavancin. In
September 2009 the US Food and Drug
Administration (FDA) approved...
- and
streptomycin therapy was used in the past. Tedizolid, telavancin,
dalbavancin, and
oritavancin antibiotics are FDA
approved as
treatments against EF...
-
fidaxomicin 2012 –
bedaquiline 2013 –
telavancin 2014 –
tedizolid 2014 –
dalbavancin 2014 – ceftolozane/tazobactam 2015 – ceftazidime/avibactam 2017 – meropenem/vaborbactam...
- in
treating endocarditis. If the VRE
strain is vanB,
teicoplanin and
dalbavancin are
suitable therapeutic options.
Another antibiotic often used as off-label...
-
infection and community-acquired
bacterial pneumonia. The
lipoglycopeptide dalbavancin and the
oxazolidinone tedizolid has also been
approved for use for the...
-
chain elongation: Vancomycin# (Oritavancin Telavancin)
Teicoplanin (
Dalbavancin) Ristocetin‡
Avoparcin Inhibit autolysin:
Corbomycin (not approved) Lipopeptides...
